A proof‐of‐concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease
Gamez, Josep, Calopa, Matilde, Muñoz, Esteban, Ferré, Aileen, Huertas, Oscar, McAllister, Kevin, Reig, Núria, Scart‐Grès, Catherine, Insa, Raúl, Kulisevsky, Jaime
Published in British journal of clinical pharmacology (01.05.2023)
Published in British journal of clinical pharmacology (01.05.2023)
Get full text
Journal Article
F40 Proof-of-concept study testing SOM3355, a VMAT2 inhibitor for the treatment of chorea in huntington’s disease
Gamez, Josep, Calopa, Matilde, Muñoz, Esteban, Ferré, Aileen, Huertas, Oscar, McAllister, Kevin, Reig, Núria, Scart-Grès, Catherine, Insa, Raul, Kulisevsky, Jaime
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2021)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2021)
Get full text
Journal Article
Triamtereno ou nolatrexed para uso no tratamento de fenilcetonúria
SIGNORILE LUCA, SANTIAGO ESTEVA GRAS, AILEEN FERRÉ FERRÉ, RAÚL INSA BORONAT, NÚRIA REIG BOLAÑO, GAL.LA PERICOT MOHR, ÓSCAR HUERTAS GAMBÍN
Year of Publication 05.10.2021
Get full text
Year of Publication 05.10.2021
Patent
페닐케톤뇨증 치료에 사용하기 위한 트리암테렌 또는 놀라트렉세드
SIGNORILE LUCA, PERICOT MOHR GAL.LA, HUERTAS GAMBIN OSCAR, ESTEVA GRAS SANTIAGO, REIG BOLANO NURIA, FERRE FERRE AILEEN, INSA BORONAT RAUL
Year of Publication 25.10.2021
Get full text
Year of Publication 25.10.2021
Patent